These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34702338)

  • 1. Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study.
    Garpenhag L; Dahlman D
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):81. PubMed ID: 34702338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare seeking among Swedish patients in opioid substitution treatment - a mixed methods study on barriers and facilitators.
    Troberg K; Lundqvist K; Hansson H; Håkansson A; Dahlman D
    Subst Abuse Treat Prev Policy; 2022 Feb; 17(1):8. PubMed ID: 35123518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective.
    Hall NY; Le L; Majmudar I; Mihalopoulos C
    Drug Alcohol Depend; 2021 Apr; 221():108651. PubMed ID: 33667783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Literacy among Swedish Patients in Opioid Substitution Treatment: A Mixed-Methods Study.
    Dahlman D; Ekefäll M; Garpenhag L
    Drug Alcohol Depend; 2020 Sep; 214():108186. PubMed ID: 32721789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma.
    Lacroix A; Puybaret V; Villéger P; Zattoni-Leroy J; Cantaloube S; Chevalier C; Nubukpo P
    Therapie; 2024; 79(3):307-317. PubMed ID: 37625937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
    Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare.
    Vikbladh T; Troberg K; Håkansson A; Dahlman D
    BMC Health Serv Res; 2022 Jul; 22(1):971. PubMed ID: 35906595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient's and healthcare provider's experiences with Opioid Maintenance Treatment (OMT): a qualitative evidence synthesis.
    Steiro A; Hestevik CH; Muller AE
    BMC Health Serv Res; 2024 Mar; 24(1):333. PubMed ID: 38481254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
    Treloar C; Rance J; Grebely J; Dore GJ
    Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directly observed hepatitis C treatment with opioid substitution therapy in community pharmacies: A qualitative study.
    Gunn J; Higgs P
    Res Social Adm Pharm; 2020 Sep; 16(9):1298-1301. PubMed ID: 31003763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
    Goeieman DS; Nonyane DS; Nzaumvila DK; Anse van Rensburg MNS
    Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e10. PubMed ID: 36744456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of Aging with Opioid Use Disorder and Comorbidity in Opioid Treatment Programs: A Qualitative Analysis.
    Han BH; Orozco MA; Miyoshi M; Doland H; Moore AA; Jones KF
    J Gen Intern Med; 2024 Jul; 39(9):1673-1680. PubMed ID: 38436883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to management of opioid withdrawal in hospitals in England: a document analysis of hospital policies on the management of substance dependence.
    Harris M; Holland A; Lewer D; Brown M; Eastwood N; Sutton G; Sansom B; Cruickshank G; Bradbury M; Guest I; Scott J
    BMC Med; 2022 Apr; 20(1):151. PubMed ID: 35418095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention stigma: How medication-assisted treatment marginalizes patients and providers.
    Madden EF
    Soc Sci Med; 2019 Jul; 232():324-331. PubMed ID: 31125801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review.
    Loh DA; Plugge E; Van Hout MC
    Int J Drug Policy; 2023 Feb; 112():103957. PubMed ID: 36693296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study.
    Shepherd A; Perrella B; Hattingh HL
    Subst Abuse Treat Prev Policy; 2014 Aug; 9():32. PubMed ID: 25108396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare.
    McCurry MK; Avery-Desmarais S; Schuler M; Tyo M; Viveiros J; Kauranen B
    J Nurs Scholarsh; 2023 May; 55(3):701-710. PubMed ID: 36317787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare.
    Bäckström E; Troberg K; Håkansson A; Dahlman D
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.